Germany – Medical gases – Medizinische Gase

Universitätsklinikum Aachen AöR · Germany government procurement

This opportunity is now closed. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

About this record

The issuing agency did not publish a description for this notice. The full record as GlobalGov received it is below.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyUniversitätsklinikum Aachen AöR
CountryGermany
CategoryPharmaceuticals
CPV24111500
PublishedSeptember 12, 2025
Procurement stageRequest for Proposal (RFP)
ClosedClosing date not published
StatusClosed — no longer accepting responses
Last verifiedOctober 11, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Browse Similar Open Opportunities in Germany

Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-09
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Sulpirid, ATC N05AL01
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Budesonid in der Darreichungsform HKM
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Naloxegol -VV 86
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Calciumcarbonat und Colecalciferol , ATC A12AX01
Germany – Pharmaceutical products – Open house drug discount contracts Fingolimod in the strength 0.25 mg, ATC L04AE01
Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient Tafluprost (ATC code: S01EE05).
Germany – Pharmaceutical products – Open house drug discount contracts Multienzyme (lipase, protease etc.), ATC A09AA02

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.